TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
TSHA

Taysha Gene Therapies Inc

Healthcare · Biotechnology · —

4.90$ -4.8% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet TSHA
Line item 2019 2020 2021 2022 2023 2024 2025
– +1,725,773.3% -17.4% -41.0% +36.8% -7.2% +114.1%
– +1,719,093.3% -38.1% -39.6% +55.4% -5.2% +128.4%
– – -40.7% -41.1% +63.8% -3.4% +130.0%
– – -40.7% -41.1% +63.8% -3.4% +130.0%
– – +17,534.1% – – – –
– +4,952.7% +1,464.5% +5.7% -22.0% -9.2% +8.5%
– +4,652.7% +625.9% +21.3% -41.5% -28.6% +1.2%
– – – – +8.2% +14.0% –
– – +991.4% -49.7% -41.8% -43.6% +74.7%
– – – +2.1% +6.7% +8.5% +14.0%
– – -62.0% -99.0% +7,796.4% -4.6% +245.2%
– – – – – – –
– -52.2% +113.1% +16.7% +164.2% +115.4% +27.8%

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?